39

2

Logo

Corify Care SL

Société |

Onglets principaux

A propos de votre organisation

CORIFY Care SL (Corify) is a medical start-up focused on cardiac arrhythmias. We are developing a novel technology to improve the treatment of atrial fibrillation, which affects more than 30M patients worldwide. Corify vision is to become the world reference company in the prognosis and treatments of patients with cardiac arrhythmias.

Corify was founded by Andreu Climent and María Guillem, biomedical engineers, together with Felipe Atienza and Francisco Fernández-Avilés, world-renowned physiologists on cardiac arrhythmias. The technology originated at Hospital Universitario Gregorio Marañón (Madrid) and Universitat Politècnica de València.

The Strategic Research Agenda for cardiovascular disease (SRA-CVD) considers the improvement of the Atrial Fibrillation (AF) treatment a priority area. There are 10,7 million AF patients across Europe. By 2050, 2% of the population will be affected by AF. The effective treatment is ablation. However, more than 60% of persistent AF require several procedures, amounting to €13,5 billion in wasted healthcare costs.

Corify has developed ACORYS, a medical device, combining high-density electrodes, innovative image and biosignals processing technology and artificial intelligence. First, it helps with the diagnosis; Second, it guides surgeons during the ablation procedure.The advantage is double: a more precise diagnosis and more efficient surgery. ACORYS has been preliminarily validated with more than 150 patients in Spain and US.

Actualités

Réseau (0)

Il n'y a pas encore d'organisations dans le réseau.

Activité récente

Vous n'êtes pas connecté(e)

Un certain nombre de contenus vous sont cachés et vous ne bénéficiez pas des fonctionnalités de mises en relation.

Log in or register pour accéder à l’intégralité des contenus et fonctionnalités d’EuroQuity : l’inscription est rapide et gratuite !